Lind Global Fund III LP

13D and 13G Filings

13D/G filings: 13G on 12 securities
Location: New York, NY
CIK: 0002071860
Form D filings: 1 filing
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Schedule 13G · 12 securities · passive
Gorilla Technology Group Inc. 13G GRRR · G4000K175	GRRR	G4000K175	10.0%	3,065,081	13G	11/2/2026 Event 10/29/2026
Lind Global Fund III LP			10.0%	3,065,081
Lind Global Partners III LLC			10.0%	3,065,081
Easton Jeff			10.0%	3,065,081
Dare Bioscience, Inc. 13G DARE · 23666P200	DARE	23666P200	5.7%	1,094,890	13G	8/28/2026 Event 8/17/2026
Lind Global Fund III LP			5.7%	1,094,890
Lind Global Partners III LLC			5.7%	1,094,890
Easton Jeff			5.7%	1,094,890
DEFSEC Technologies Inc. 13G DFSC · 244778106	DFSC	244778106	10.0%	347,315	13G	8/25/2026 Event 8/18/2026
Lind Global Fund III LP			10.0%	347,315
Lind Global Partners III LLC			10.0%	347,315
Easton Jeff			10.0%	347,315
Enveric Biosciences, Inc. 13G/A ENVB · 29405E505	ENVB	29405E505	1.4%	51,866	13G/A	8/14/2026 Event 6/30/2026
Lind Global Fund III LP			1.3%	49,366
Lind Global Partners III LLC			1.3%	49,366
Easton Jeff			1.4%	51,866
Iveda Solutions, Inc. 13G/A IVDA · 46583A303	IVDA	46583A303	10.0%	1,286,794	13G/A	8/14/2026 Event 6/30/2026
Lind Global Fund III LP			10.0%	1,286,794
Lind Global Partners III LLC			10.0%	1,286,794
Jeff Easton			10.0%	1,286,794
Nuwellis, Inc. 13G NUWE · 67113Y801	NUWE	67113Y801	6.2%	193,050	13G	8/5/2026 Event 8/3/2026
Lind Global Fund III LP			6.2%	193,050
Lind Global Partners III LLC			6.2%	193,050
Easton Jeff			6.2%	193,050
60 Degrees Pharmaceuticals, Inc. 13G SXTP · 83006G500	SXTP	83006G500	5.5%	191,571	13G	8/5/2026 Event 7/31/2026
Lind Global Fund III LP			5.5%	191,571
Lind Global Partners III LLC			5.5%	191,571
Easton Jeff			5.5%	191,571
C3is Inc. 13G CISS · Y18284300	CISS	Y18284300	10.0%	1,325,482	13G	7/31/2026 Event 6/28/2026
Lind Global Fund III LP			10.0%	1,325,482
Lind Global Partners III LLC			10.0%	1,325,482
Easton Jeff			10.0%	1,325,482
Innovation Beverage Group Ltd 13G/A IBG · Q4933C208	IBG	Q4933C208	4.99%	56,139	13G/A	5/15/2026 Event 3/31/2026
Lind Global Fund III LP			4.99%	56,139
Lind Global Partners III LLC			4.99%	56,139
Easton Jeff			4.99%	56,139
Silexion Therapeutics Corp 13G/A SLXN · G1281K122	SLXN	G1281K122	4.96%	212,500	13G/A	5/15/2026 Event 3/31/2026
Lind Global Fund III LP			4.96%	212,500
Lind Global Partners III LLC			4.96%	212,500
Easton Jeff			4.96%	212,500
FibroBiologics, Inc. 13G FBLG · 31573L204	FBLG	31573L204	4.99%	230,234	13G	4/9/2026 Event 4/2/2026
Lind Global Fund III LP			4.99%	230,234
Lind Global Partners III LLC			4.99%	230,234
Easton Jeff			4.99%	230,234
Bionano Genomics, Inc. 13G/A BNGO · 09075F404	BNGO	09075F404	9.4%	1,050,000	13G/A	2/17/2026 Event 12/31/2025
Lind Global Fund III LP			9.4%	1,050,000
Lind Global Partners III LLC			9.4%	1,050,000
Easton Jeff			9.4%	1,050,000

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.